Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 204-435-9 | CAS number: 120-92-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Key value for chemical safety assessment
Genetic toxicity in vitro
Description of key information
Several genotoxicin vitro tests are available on Cyclopentanone. Two have been selected as key study. A complete Ames test performed in 2015 (reliability 1) and chromosome aberration test conducted in 2007 (reliability 1). The other tests available on cyclopentanone have been selected as supporting studies. A mutation test on mammalian cells is missing on cyclopentanone. This gap has been fulfilled by a read-across with cyclohexanone.
Link to relevant study records
- Endpoint:
- in vitro gene mutation study in bacteria
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- from 2014-11-28 to 2015-04-03
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: OECD 471 guideline study in compliance with the GLP. No deviation from the protocol of the study.
- Reason / purpose for cross-reference:
- reference to same study
- Reason / purpose for cross-reference:
- reference to other study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
- Deviations:
- no
- Principles of method if other than guideline:
- Not applicable.
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- bacterial reverse mutation assay
- Target gene:
- - Histidine: TA 1535, TA 100, TA 1537 and TA 98
-Tryptophan: Escherichia coli WP2 uvr A - Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
- Details on mammalian cell type (if applicable):
- Not applicable
- Additional strain / cell type characteristics:
- other: see Table 7.6.1/1
- Species / strain / cell type:
- E. coli WP2 uvr A
- Details on mammalian cell type (if applicable):
- Not applicable
- Additional strain / cell type characteristics:
- other: see Table 7.6.1/1
- Metabolic activation:
- with and without
- Metabolic activation system:
- S9 from induced phenobarbital/Beta-naphthoflavone rat liver.
- Test concentrations with justification for top dose:
- - Range finding test: 10; 100; 500; 1000; 2500 and 5000 µg/plate
- First experiment (Direct plate incorporation method, with and without metabolic activation): 312.5, 625, 1250, 2500 and 5000 µg/plate
- Second experiment (Direct plate incorporation method, without metabolic activation) (Pre-incubation method, with metabolic activation): 312.5, 625, 1250, 2500 and 5000 µg/plate - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: water for injections, batch No. 4F1081 (CDM Lavoisier)
- Justification for choice of solvent/vehicle: the substance was soluble in water (solubility: 301 g/l at 20°C) - Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- Remarks:
- water
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- 9-aminoacridine
- 2-nitrofluorene
- sodium azide
- benzo(a)pyrene
- methylmethanesulfonate
- other: 4-nitroquinoline 1-oxide (4NQO); 2-anthramine (2AM)
- Remarks:
- see Table 7.6.1/2
- Details on test system and experimental conditions:
- METHOD OF APPLICATION:
The preliminary test, both experiments without S9 mix and the first experiment with S9 mix were performed according to the direct plate
incorporation method in agar. The second experiment with S9 mix was performed according to the pre-incubation method.
DURATION
- Incubation period: at 37°C for 48 to 72 hours.
- Preincubation period: 60 min at 37ºC.
NUMBER OF REPLICATIONS: 3 plates/dose/strain. Two independent experiments were performed.
DETERMINATION OF CYTOTOXICITY
- Method: The evaluation of the toxicity was performed on the basis of the observation of the decrease in the number of revertant colonies and/or a
thinning of the bacterial lawn.
OTHER: SCORING METHOD: the number of revertants per plate was scored for each strain and for each experimental point using an automatic counter (Sorcerer Automatic Colony Counter for the scoring of colonies and Ames Study Manager for the data management, Perceptive Instruments Ltd, Bury St Edmunds IP33 3TA, UK). - Evaluation criteria:
- Acceptance criteria :
Each main experiment was considered valid if the following criteria are fully met:
- the mean number of revertants in the vehicle controls is consistent with our historical data, in each strain and test condition (Appendix 2),
- at least five analyzable dose-levels (i.e. including at least three non-cytotoxic dose-levels) are obtained for each strain and test condition,
- the mean number of revertants in the positive controls is higher than that of the vehicle controls (at least 2-fold increase (for the TA 98, TA 100 and WP2 uvrA strains) or at least 3-fold increase (for the TA 1535 and TA 1537 strains)).
When these criteria were not met for one strain or test condition, the corresponding results were invalidated and the experiment was repeated.
Evaluation criteria :
In all cases, biological relevance (such as reproducibility and reference to historical data) was taken into consideration when evaluating the results.
The test item is considered to have shown mutagenic activity in this study if:
- a reproducible 2-fold increase (for the TA 98, TA 100 and WP2 uvrA strains) or 3-fold increase (for the TA 1535 and TA 1537 strains) in the mean number of revertants compared with the vehicle controls is observed, in any strain, at any dose-level,
- and/or a reproducible dose-response relationship is evidenced.
The test item is considered to have shown no mutagenic activity in this study if:
- neither an increase in the mean number of revertants, reaching 2-fold (for the TA 98, TA 100 and WP2 uvrA strains) or 3-fold (for the TA 1535 and TA 1537 strains) the vehicle controls value, is observed at any of the tested dose-levels,
- nor any evidence of a dose-response relationship is noted. - Statistics:
- No data
- Species / strain:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and E. coli WP2
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Precipitation: no
RANGE-FINDING/SCREENING STUDIES:
To assess the toxicity of the test item to the bacteria, six dose-levels (one plate/dose-level) were tested in the TA 98, TA 100 and WP2 uvrA strains, both with and without S9 mix.
Using a test item concentration at 50 mg/mL in the vehicle and a treatment volume of 100 µL/plate, the highest recommended dose-level of 5000 µg/plate was achievable. Thus, the dose-levels selected for the preliminary test were 10, 100, 500, 1000, 2500 and 5000 µg/plate. The evaluation of the
toxicity was performed on the basis of the observation of the decrease in the number of revertant colonies and/or a thinning of the bacterial lawn.
No precipitate was observed in the Petri plates when scoring the revertants at any of the tested dose levels. No noteworthy toxicity was noted towards the three strains used, either with or without S9 mix.
COMPARISON WITH HISTORICAL CONTROL DATA: The control data reported in these report are in the range of the historical control data observed in the laboratory. The study was therefore considered valid.
ADDITIONAL INFORMATION ON CYTOTOXICITY: No toxicity was noted towards all the strains used. - Remarks on result:
- other: all strains/cell types tested
- Remarks:
- Migrated from field 'Test system'.
- Conclusions:
- Interpretation of results (migrated information):
negative (with and without metabolic activation)
Under the experimental conditions of this study, the test item Cyclopentanone did not show any mutagenic activity in the bacterial reverse mutation test with Salmonella typhimurium and Escherichia coli strains, either in the presence or in the absence of a rat liver metabolizing system. - Executive summary:
This study was performed to investigate the potential of the test item, Cyclopentanone, to induce reverse mutations in Salmonella typhimurium and Escherichia coli. The study was performed according to OECD guideline no. 471 and EC guideline n° B13/14 and in compliance with the Principles of Good Laboratory Practice.
A preliminary toxicity test was performed to define the dose-levels of Cyclopentanone to be used for the mutagenicity study. The test item was then tested in two independent experiments, both with and without a metabolic activation system, the S9 mix, prepared from a liver post‑mitochondrial fraction (S9 fraction) of rats induced with Aroclor 1254.
Both experiments were performed according to the direct plate incorporation method except for the second test with S9 mix, which was performed according to the pre-incubation method (60 minutes, 37°C).
Four strains of bacteria Salmonella typhimurium (TA 1535, TA 1537, TA 98, TA 100) and one strain of Escherichia coli (WP2 uvrA) were used. Each strain was exposed to five dose-levels of the test item (three plates/dose‑level). After 48 to 72 hours of incubation at 37°C, the revertant colonies were scored.
The evaluation of the toxicity was performed on the basis of the observation of the decrease in the number of revertant colonies and/or a thinning of the bacterial lawn.
The test item was dissolved in water for injections.
The test item was freely soluble in the vehicle at 50 mg/mL. Consequently, with a maximum dose-volume of 100 µL/plate, the dose-levels for the preliminary toxicity test were 10, 100, 500, 1000, 2500 and 5000 µg/plate.
No precipitate was observed in the Petri plates when scoring the revertants at any of the tested dose‑levels, and no noteworthy toxicity was noted towards the three strains used, either with or without S9 mix.
Since the test item was freely soluble and non-toxic in the preliminary test, the highest dose-level selected for the main experiments was 5000 µg/plate, according to the criteria specified in the international guidelines.
The number of revertants for the vehicle and positive controls was as specified in the acceptance criteria. The study was therefore considered valid.
The selected treatment-levels were 312.5, 625, 1250, 2500 and 5000 µg/plate, for both mutagenicity experiments with and without S9 mix.
No precipitate was observed in the Petri plates when scoring the revertants at any of the tested dose‑levels, and no toxicity was noted towards all the strains used.
The test item did not induce any noteworthy increase in the number of revertants, in any of the five tested strains, either with or without S9 mix. These results met thus the criteria of a negative response.
Under the experimental conditions of this study, the test item Cyclopentanone did not show any mutagenic activity in the bacterial reverse mutation test with Salmonella typhimurium and Escherichia coli strains, either in the presence or in the absence of a rat liver metabolizing system.
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- from 18 jan 2007 TO 24 MAY 2007
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP study according to guideline with pure test substance.
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 473 (In Vitro Mammalian Chromosome Aberration Test)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- in vitro mammalian chromosome aberration test
- Species / strain / cell type:
- lymphocytes: Human
- Details on mammalian cell type (if applicable):
- - Type and identity of media:
Blood samples were obtained from healthy donors not receiving medication. For this study, blood was collected from a female donor
(26 year-old) for Experiment I, and from a 44 year old male donor for Experiment II.
Blood samples were drawn by venous puncture and collected in heparinized tubes by Dr. V. Theodor (64380 Rossdorf, Germany).
The tubes were sent to RCC-CCR to initiate cell cultures within 24 hrs after blood collection. If necessary, the blood was stored before use at 4° C. - Metabolic activation:
- with and without
- Metabolic activation system:
- Phenobarbital/beta-naphthoflavone induced rat liver S9 (from 8 - 12 weeks old male Wistar HanIbm rats, weight approx. 220 - 320 g) for details see "details on test system & conditions"
- Test concentrations with justification for top dose:
- Doses levels were:
0; 277.6; 485.7 and 850 µg/mL with or without S9 mix - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: deionised water
- Justification for choice of solvent/vehicle: The solvent was chosen to its solubility properties and its relative nontoxicity to the cell cultures.
- volume of vehicle/solvent in the medium: 10% - Untreated negative controls:
- no
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- other: for details see "details on test system & conditions"
- Details on test system and experimental conditions:
- METABOLIC ACTIVATION SYSTEM: (details)
Phenobarbital/beta-naphthoflavone induced rat liver S9 (from 8 - 12 weeks old male Wistar HanIbm rats, weight approx. 220 - 320 g induced
by applications of 80 mg/kg b.w. phenobarbital i.p. (Desitin; 22335 Hamburg, Germany) and beta-naphthoflavone p.o. (Aldrich, 89555 Steinheim,
Germany) each, on three consecutive days. The livers were prepared 24 hours after the last treatment. The S9 fractions were produced by dilution
of the liver homogenate with a KCl solution (1+3) followed by centrifugation at 9000 g. Aliquots of the supernatant were frozen and stored in
ampoules at -80° C. Small numbers of the ampoules can be kept at -20°C for up to one week.
The protein concentration of the S9 preparation was 25.3 mg/mL (Lot no. 061006) in both experiments.)
POSITIVE CONTROL(S) SUBSTANCE
> without S9 mix:
ethylmethanesulphonate
770.0 µg/mL (6.21 mM) (22 hrs preparation interval)
660.0 µg/mL (5.32 mM) (22 hrs preparation interval)
495.0 µg/mL (3.98 mM) (46 hrs preparation interval)
Remark: Solutions were prepared on the day of experiment. The stability of the positive control substance in solution was proven by the mutagenic
response in the expected range.
> with S9 mix:
cyclophosphamide
30.0 µg/mL (0.106 mM)
Remark: The dilutions of the stock solutions were prepared on the day of experiment. The stability of CPA in solution at room temperature is good.
At 25° C only 3.5 % of its potency is lost after 24 hours
DETAILS ON TEST SYSTEM AND CONDITIONS
> PRELIMINARY TEST:
- METHOD OF APPLICATION: in medium
- DURATION:
- Exposure duration: 4h-22h-46h
> EXPERIMENT I & II
- METHOD OF APPLICATION: in medium
- DURATION:
exposure period duraition
Without S9 mix With S9 mix
Exp. I Exp. II Exp. I Exp. II
Exposure period 4 hrs-22 hrs 46 hrs 4 hrs 4 hrs
Recovery 18 hrs 18 hrs 42 hrs
Preparation interval 22 hrs-22 hrs 46 hrs 22 hrs 46 hrs
Selection time
-spindle inhibition: colcemid
- stain : Giemsa
- number of replication: 22h # 1,5 fold of the normal cell time
NUMBER OF CELLS EVALUATED :
In each experimental group two parallel cultures were analysed. 100 metaphase plates per culture were scored for structural chromosomal
aberrations. 1000 cells were counted per culture for determination of mitotic index.
DETERMINATION OF CYTOTOXICITY
- Method: mitotic index
OTHER EXAMINATIONS:
- Determination of polyploidy: the number of polyploid cells in 250 metaphase cells (% polyploid metaphases) was scored
OTHER: SCORING METHOD:
The slides were evaluated (according to standard protocol of the "Arbeitsgruppe der Industrie, Cytogenetik" ) using NIKON microscopes
with 100 x oil immersion objectives. Breaks, fragments, deletions, exchanges and chromosomal disintegrations were recorded as structural
chromosome aberrations. Gaps were recorded as well, but they were not included in the calculation of the aberration rates . 100 well spread
metaphase plates per culture were scored for cytogenetic damage on coded slides. Only metaphases with 46+/-1 centromer regions were
included in the analysis. - Evaluation criteria:
- - A test item is classified as non-mutagenic if:
* the number of induced structural chromosome aberrations in all evaluated dose groups is in the range of our historical control data
(0.0 - 4.0 % aberrant cells, excluding gaps).
* no significant increase of the number of structural chromosome aberrations is observed.
- A test item is classified as mutagenic if:
* the number of induced structural chromosome aberrations is not in the range of our historical control data
(0.0 -4.0 % aberrant cells, excluding gaps).
and
* either a concentration-related or a significant increase of the number of structural chromosome aberrations is observed.
Although the inclusion of the structural chromosome aberrations is the purpose of this study, it is important to include the polyploids and
endoreduplications. The following criteria is valid:
A test item can be classified as aneugenic if:
- the number of induced numerical aberrations is not in the range of our historical control data (0.0 - 1.5 % % polyploid cells). - Statistics:
- Statistical significance was confirmed by means of the Fisher´s exact test (p < 0.05). However, both biological and statistical significance should
be considered together. If the above mentioned criteria for the test item are not clearly met, the classification with regard to the historical data and
the biological relevance is discussed and/or a confirmatory experiment is performed. - Species / strain:
- lymphocytes: Human
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- no (no visible precipitation no increase in osmolality or pH value)
COMPARISON WITH HISTORICAL CONTROL DATA: yes
ADDITIONAL INFORMATION ON CYTOTOXICITY: no - Remarks on result:
- other: other: Human lymphocytes
- Remarks:
- Migrated from field 'Test system'.
- Conclusions:
- Interpretation of results (migrated information):
negative with metabolic activation
negative without metabolic activation
Negative with and without metabolic activation - Executive summary:
The test item Cyclopentanone distilled (99.9%), dissolved in deionised water, was assessed for its potential to induce structural chromosome aberrations in human lymphocytes in vitro in two independent experiments.
The following study design was performed:
Without S9 mix
With S9 mix
Exp. I
Exp. II
Exp. I
Exp. II
Exposure period
4 hrs-22 hrs
46 hrs
4 hrs
4 hrs
Recovery
18 hrs
18 hrs
42 hrs
Preparation interval
22 hrs-22 hrs
46 hrs
22 hrs
46 hrs
In each experimental group two parallel cultures were set up. Per culture 100 metaphase plates were scored for structural chromosome aberrations.
The highest applied concentration in this study (850.0 µg/mL, 10 mM) was chosen with respect to the current OECD Guideline 473.
In both independent experiments, neither a statistically significant nor a biologically relevant increase in the number of cells carrying structural chromosomal aberrations was observed after treatment with the test item.
No relevant increase in the frequencies of polyploid metaphases was found after treatment with the test item as compared to the frequencies of the controls.
Appropriate mutagens were used as positive controls. They induced statistically significant increases (p 0.05) in cells with structural chromosome aberrations.
In conclusion, it can be stated that under the experimental conditions reported, the test item did not induce structural chromosome aberrations as determined by the chromosome aberration test in human lymphocytes in vitro.
Therefore, Cyclopentanone distilled is considered to be non-clastogenic in this chromosome aberration test in the absence and presence of metabolic activation.
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Remarks:
- Type of genotoxicity: gene mutation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: The purity of the substance was unknown. The protocol and the criteria of evaluation were well described.
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 476 (In Vitro Mammalian Cell Gene Mutation Test)
- Deviations:
- not specified
- Principles of method if other than guideline:
- In vitro mammalian cell gene mutation tests
- GLP compliance:
- not specified
- Type of assay:
- mammalian cell gene mutation assay
- Species / strain / cell type:
- mouse lymphoma L5178Y cells
- Details on mammalian cell type (if applicable):
- - Type and identity of media: Fischer medium supplemented with 2 mM L-glutamine, sodium pyruvate, 110 µg/mL, 0.05% pluronic F68, antibiotics, and 10% heat-inactivated donor horse serum
- Periodically checked for Mycoplasma contamination: yes
- Periodically "cleansed" against high spontaneous background: yes - Metabolic activation:
- with and without
- Metabolic activation system:
- S9 mix was prepared from rat liver induced with Aroclor 1254
- Test concentrations with justification for top dose:
- 0, 312.5, 625, 1750, 2500, 5000 µg/mL
- Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: distilled water or DMSO
No more data - Untreated negative controls:
- not specified
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- not specified
- Positive controls:
- yes
- Positive control substance:
- other: 3-Methylcholanthrene (3-MC, concentration unknown); Ethyl methanesulphonate (EMS, concentration unknown
- Details on test system and experimental conditions:
- - Method of application: in medium
- Duration:
* Exposure duration: 4 hours
* Expression time: 48 hours
* Selection time: 11-14 days
- Selection agent: trifluorothymidine (3 µg/mL)
- Number of replicates: 3
DETERMINATION OF CYTOTOXICITY:
- Method: relative total growth (RTG)
OTHER: colonies were counted using an Artek 880 Automated Colony Counter, with the colony size discriminator control in the "off" position. - Evaluation criteria:
- * Positive (+): a test was considered as positive when, out of 3 trials, a positive trial was reproducible.
* Negative (-): a test was considered as negative, when, out of 3 trials, a positive response or a positive dose was not reproducible
* Questionable (?): a test was considered as questionable when, out of 3 trials, neither a positive nor a negative response was reproduced - Statistics:
- The statistical analysis was based upon the mathematical model proposed fort his system and consisted of a dose-trend test and a variance analysis of pair-wise comparisons of each dose against the vehicle control.
- Species / strain:
- mouse lymphoma L5178Y cells
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Remarks:
- > 5000 µg/mL
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not specified
- Positive controls validity:
- valid
- Additional information on results:
- Tables in the publication are not exploitable (illegible)
- Remarks on result:
- other: all strains/cell types tested
- Remarks:
- Remarks: L5178Y tk+/tk- Mouse Lymphoma cell forward mutation assay.
- Conclusions:
- Interpretation of results (migrated information):
negative
Negative with and without metabolic activation.
- Executive summary:
In a mammalian cell gene mutation assay in L5178Y mouse lymphoma cells (McGregor DB, 1988), cells cultured in vitro were exposed to cyclohexanone (purity unknown) at concentrations of 0, 312.5, 625, 1750, 2500, 5000 µg/mL in the presence and absence of mammalian metabolic activation (S9-mix from rat liver induced with Aroclor 1254). No significant reduction in survival or increase in mutant fraction occurred in either the presence or absence of S9 mix at cyclohexanone concentrations up to 5000 µg/mL.
- Endpoint:
- in vitro gene mutation study in mammalian cells
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Justification for type of information:
- See below attached read-across justification.
- Species / strain:
- mouse lymphoma L5178Y cells
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not specified
- Positive controls validity:
- valid
- Remarks on result:
- other:
- Remarks:
- data on a analogue (cyclohexanone)
- Executive summary:
Read accross with Cyclohexanone was used for mutations in mammalian cells:
Summary of the study in mammalin cells for cyclohexanone:
In a mammalian cell gene mutation assay in L5178Y mouse lymphoma cells (McGregor DB, 1988), cells cultured in vitro were exposed to cyclohexanone (purity unknown) at concentrations of 0, 312.5, 625, 1750, 2500, 5000 µg/mL in the presence and absence of mammalian metabolic activation (S9-mix from rat liver induced with Aroclor 1254). No significant reduction in survival or increase in mutant fraction occurred in either the presence or absence of S9 mix at cyclohexanone concentrations up to 5000 µg/mL. Cyclohexanone does not induce mutation in mammalian cells. Threfore, by analogy, cyclopentanone is expected to not induce mutation in mammalian cells.
Referenceopen allclose all
See attached document
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
Table 1: Summary of results of the chromosomal aberration study with Cyclopentanone distilled
Exp. | Preparation | Test item | Polyploid | Mitotic indices | Aberrant cells | ||
interval | concentration | cells | in % | in % | |||
in µg/mL | in % | of control | incl. gaps* | excl. gaps* | with exchanges | ||
Exposure period 4 hrs without S9 mix | |||||||
I | 22 hrs | Solvent control1 | 0.0 | 100.0 | 1.0 | 1.0 | 0.0 |
Positive control2 | 0.0 | 105.6 | 9.0 | 8.0S | 2.0 | ||
277.6 | 0.0 | 114.0 | 0.0 | 0.0 | 0.0 | ||
485.7 | 0.0 | 121.0 | 0.0 | 0.0 | 0.0 | ||
850.0 | 0.0 | 123.8 | 1.0 | 1.0 | 0.0 | ||
Exposure period 22 hrs without S9 mix | |||||||
I | 22 hrs | Solvent control1 | 0.0 | 100.0 | 0.5 | 0.0 | 0.0 |
Positive control3 | 0.0 | 35.8 | 12.0 | 11.0S | 2.5 | ||
277.6 | 0.2 | 88.6 | 1.0 | 1.0 | 0.0 | ||
485.7 | 0.0 | 81.0 | 1.5 | 1.5 | 0.0 | ||
850.0 | 0.0 | 82.9 | 1.0 | 1.0 | 0.0 | ||
Exposure period 46 hrs without S9 mix | |||||||
II | 46 hrs | Solvent control1 | 0.0 | 100.0 | 1.5 | 1.5 | 0.0 |
Positive control4 | 0.0 | 81.5 | 10.5 | 10.0S | 4.5 | ||
277.6 | 0.0 | 77.2 | 1.5 | 1.5 | 0.0 | ||
485.7 | 0.0 | 65.6 | 1.0 | 1.0 | 0.0 | ||
850.0 | 0.0 | 69.5 | 2.0 | 1.5 | 0.0 |
* Including cells carrying exchanges
S Aberration frequency statistically significant higher than corresponding control values
1 Deionised water 10.0 % (v/v)
2 EMS 770.0 µg/mL
3 EMS 660.0 µg/mL
4 EMS 495.0 µg/mL
Summary of results of the chromosomal aberration study with Cyclopentanone distilled
Exp. | Preparation interval | Test item concentration in µg/ml | Polyploid cells in % | Mitotic indices in % of control | Aberrant cells in % | ||
incl. gaps* | excl. gaps* | with exchanges | |||||
Exposure period 4 hrs with S9 mix | |||||||
I | 22 hrs | Solvent control1 | 0.0 | 100.0 | 2.0 | 1.5 | 0.0 |
Positive control2 | 0.0 | 48.5 | 16.5 | 15.5S | 0.5 | ||
277.6 | 0.0 | 93.0 | 1.0 | 1.0 | 0.0 | ||
485.7 | 0.0 | 102.0 | 0.5 | 0.5 | 0.0 | ||
850.0 | 0.0 | 106.0 | 2.0 | 1.0 | 0.0 | ||
II | 46 hrs | Solvent control1 | 0.0 | 100.0 | 2.0 | 1.5 | 0.0 |
Positive control2 | 0.0 | 26.0 | 7.5 | 7.5S | 3.0 | ||
277.6 | 0.2 | 87.7 | 2.5 | 2.0 | 0.0 | ||
485.7 | 0.0 | 116.7 | 1.5 | 1.0 | 0.0 | ||
850.0 | 0.2 | 87.4 | 1.5 | 1.5 | 0.0 |
* Including cells carrying exchanges
S Aberration frequency statistically significant higher than corresponding control values
1 Deionised water 10.0 % (v/v)
2 CPA 30.0 µg/mL
ACCEPTABILITY
OF THE ASSAY
The chromosomal aberration assay
is considered acceptable if it meets the following criteria:
a) The number of aberrations found in the solvent controls falls within
the range of historical laboratory control data range: 0.0 - 4.0 %
aberrant cells, excluding gaps.
b) The positive control substances should produce significant increases
in the number of cells with structural chromosome aberrations, which are
within the range
of
the laboratory's historical control data:
Test group Final concentration |
Aberrant cells in % (excl. gaps) Range |
Test group Final concentration |
Aberrant cells in % (excl. gaps) Range |
Without S9 mix |
With S9 mix |
||
EMS 330 - 770 µg/ml |
7.5 - 47.0 % |
CPA 15.0 - 37.5 µg/mL |
7.5 - 41.0 |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (negative)
Genetic toxicity in vivo
Description of key information
No in vivo tests are available. Conclusion can be drawn only based on the in vitro studies.
Additional information
Two studies with reliability 1 according to Klimisch rating were available and were selected as key study. Results were negative in complete Ames test with and without metabolic activation (Rhodia report, Citox Lab. 2015), and negative in chromosomal aberration in human lymphocytes, with and without metabolic activation (Rhodia report, RCC 2007). Two other studies on Cyclopentanone were available and were selected as supporting studies. Results were negative in simplified Ames test with and without metabolic activation (RTC, 1999), negative in a complete Ames test (Florin, 1980).
Three other studies on Cyclohexanone were available with reliability 2 according to Klimisch rating. Results for these studies were negative in a Ames test with and without metabolic activation, negative in a chromosomal aberration test in human lymphocytes with or without metabolic activation and negative in a mammalian cell gene mutation assay in L5178Y mouse lymphoma cells. Only the last study (mutation in mammalian cell test) has been reported in the IUCLID since the other tests are available on cyclopentanone. A read-across with cyclohexanone was done only for mutation in mammalian cells (see justification of the read-acroos) in order to fulfil the gap.
Justification for classification or non-classification
Based on negative cyclopentanone and cyclohexanone in vitro data, no genotoxic classification is required for cyclopentanone.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.